Blanket Purchase Agreement 36F79719D0024-36C26324A0006

This Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) to Abbott Laboratories Inc. provides automated chemistry and immunochemistry instrumentation, reagents, and related services to support clinical laboratory operations across VA healthcare facilities. The single-award, firm fixed-price contract, with a total ceiling value of $6,640,812.54, was established under the General Services Administration (GSA) Federal Supply Schedule for Critical Analyzers and Laboratory Equipment (FSS-66-III). The contract period of performance runs through September 30, 2025, with no set-aside designation used. Abbott Laboratories, a global healthcare company, will deliver a comprehensive range of advanced medical diagnostic equipment, testing supplies, and clinical services to the VA, leveraging its extensive experience as a prime contractor for federal agencies including the VA, Department of Defense, and Department of Justice. The contracted products and services will enable the VA to streamline procurement and rapidly fulfill requirements for chemistry and immunochemistry testing to support the provision of healthcare services to veterans.

The BPA includes multiple delivery orders and call orders placed against the master agreement, with individual contract values ranging from $33,473.03 to $1,703,996.85. These task orders cover the full spectrum of clinical laboratory testing capabilities, including infectious disease diagnostics, immunoassay services, Hepatitis and HIV testing, SARS-CoV-2 screening, and specialized clinical chemistry analysis. The contract will be performed at Abbott's facilities in North Chicago, Illinois, leveraging the company's extensive manufacturing and distribution capabilities to deliver these critical medical technologies and services to the VA nationwide.